Physician profile
Christopher Senkowski
NPI 1114956034
$43,000.58
in general payments reported to CMS, 2019-2025
13 companies · $1,875 in 2025
The $1,875 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $2,800 · 2021: $2,063 · 2022: $2,608 · 2023: $11K · 2024: $391 · 2025: $1,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,540 · Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,540.00 |
| Food and Beverage | $831.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $38,183.99 | 2019-2025 | |
| C. R. Bard, INC. & Subsidiaries | $2,428.92 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $1,540.00 | 2025 | Product In Development |
| Intuitive Surgical, INC. | $358.62 | 2019-2024 | |
| Conmed Corporation | $141.75 | 2024 | Airseal |
| Boston Scientific Corporation | $141.25 | 2024 | Spyglass Discover |
| Smith+Nephew, INC. | $54.72 | 2023-2024 | Stravix, Grafix Pl |
| Polynovo North America LLC | $39.31 | 2023 | |
| Becton, Dickinson and Company | $33.34 | 2024 | Phasix Mesh |
| Astrazeneca Pharmaceuticals LP | $24.91 | 2023 | Tagrisso |
| Novo Nordisk INC | $20.11 | 2022 | |
| Medtronic, INC. | $17.26 | 2021 | |
| Covidien LP | $16.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Senkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.